IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients-Reference-Cited by-同舟云学术

IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients

Published:2021-06-07 Issue:1 Volume:20 Page:121-129
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Khalil Fatma Omar¹^ORCID,Alsebaey Ayman²^ORCID,Kasemy Zeinab Abdelaziz³^ORCID,Abdelmageed Sabry Moawad⁴,Bedair Hanan Mosaad⁵,Abdelsattar Shimaa⁴^ORCID

Affiliation:

1. Department of Microbiology and Immunology, National Liver Institute, Egypt

2. Department of Hepatology and Gastroenterology, National Liver Institute, Egypt

3. Department of Public Health and Community Medicine, Faculty of Medicine, Egypt

4. Department of Clinical Biochemistry and Molecular Diagnostics, National Liver Institute, Egypt

5. Department of Clinical Pathology, National Liver Institute, Menoufia University, Shebeen El-Koom, Egypt

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2021.1935239

Reference35 articles.

1. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection

2. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis

3. Inflammasome activation and function in liver disease

4. Pattern Recognition Receptors: Significance of Expression in the Liver

5. Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering hepatocellular carcinoma pathogenesis and therapeutics: a study on anoikis, ceRNA regulatory network and traditional Chinese medicine;Frontiers in Pharmacology;2024-01-12